Stocks and Investing
by (remove) : Joon Lee
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Joon Lee
RSSJSONXMLCSV
Tue, September 17, 2024
Thu, September 5, 2024
Wed, August 14, 2024
Mon, August 5, 2024
Mon, July 22, 2024
Fri, June 28, 2024
Tue, June 25, 2024
Mon, June 17, 2024
Thu, May 16, 2024
Wed, May 15, 2024
Mon, April 1, 2024
Tue, March 26, 2024
Mon, March 25, 2024
Tue, March 5, 2024
Thu, February 29, 2024
Thu, December 21, 2023
Wed, December 20, 2023
Mon, December 4, 2023
Wed, November 29, 2023
Wed, November 1, 2023
Mon, October 2, 2023
Wed, September 20, 2023
Tue, September 5, 2023
Wed, August 16, 2023
Tue, August 15, 2023
Tue, June 27, 2023
Fri, June 23, 2023
Wed, June 7, 2023

Joon Lee Maintained (BMRN) at Strong Buy with Decreased Target to $90 on, Sep 17th, 2024


Published on 2024-10-28 14:19:17 - WOPRAI, Joon Lee
  Print publication without navigation


Joon Lee of Truist Securities, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $118 to $90 on, Sep 17th, 2024.

Joon has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Joon's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whitney Ijem of "Canaccord Genuity" Maintained at Hold and Held Target at $93 on, Friday, September 13th, 2024
  • Joel Beatty of "Baird" Downgraded from Buy to Hold and Decreased Target to $72 on, Friday, May 17th, 2024


These are the ratings of the 6 analyists that currently disagree with Joon


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $110 on, Monday, September 9th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $122 on, Thursday, September 5th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $120 on, Thursday, September 5th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Increased Target to $115 on, Tuesday, August 6th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $110 on, Tuesday, August 6th, 2024
  • Phil Nadeau of "TD Cowen" Maintained at Strong Buy with Decreased Target to $120 on, Tuesday, August 6th, 2024
Contributing Sources